Pilot study of docetaxel combined with lobaplatin or gemcitabine for recurrent and metastatic breast cancer.
Li F, Wang B, He M, Chang J, Li J, Shan L, Wang H, Hong W, Luo D, Song Y, Liu L, Li H, Ran L, Chen T.
Li F, et al. Among authors: wang h, wang b.
Medicine (Baltimore). 2019 Dec;98(52):e18513. doi: 10.1097/MD.0000000000018513.
Medicine (Baltimore). 2019.
PMID: 31876741
Free PMC article.
Clinical Trial.